...
首页> 外文期刊>The American journal of drug and alcohol abuse >Establishment of an alcoholic fatty liver disease model in mice
【24h】

Establishment of an alcoholic fatty liver disease model in mice

机译:小鼠含酒精脂肪肝病模型的建立

获取原文
获取原文并翻译 | 示例

摘要

Background: Alcoholic fatty liver disease (AFLD) defines an important stage in the progression of alcoholic liver disease (ALD), which is a major cause of morbidity and mortality worldwide. Objective: To establish a mouse model of AFLD. Methods: Male C57BL/6 mice were divided into the following two groups: (i) a control group, which was allowed free access to food and water and (ii) an alcohol-treated group, which was administered a 15% (v/v) alcohol solution instead of water. After 8-9 months of treatment, serum biochemical indexes, histopathological changes, liver triglyceride content, iron storage, and ferritin light chain protein expression were measured using an automatic biochemical analyzer, hematoxylin-eosin (HE) staining, a commercially available kit, Prussian blue staining, and Western blot analysis, respectively. Results: Compared with the control group, the alcohol-treated group displayed increased levels of serum LDH, ALT, and AST, decreased levels of ALB, and no significant change in levels of TP. Additionally, increased levels of serum TG, T-CHO, and LDL and decreased levels of serum GLU and HDL were observed in the alcohol-treated mice. HE staining showed that lipid vacuolization occurred in the livers of alcohol-treated mice. The alcohol-treated mice also exhibited increased liver triglyceride content. Moreover, Prussian blue staining and Western blot analysis demonstrated that chronic alcohol administration caused iron overloading of the liver. Conclusions: Chronic administration of 15% (v/v) alcohol in the drinking water over 8-9 months caused AFLD in mice. Our results establish an AFLD model that represents a promising tool for the future study of the progression of ALD.
机译:背景:酒精脂肪肝疾病(AFLD)在含酒精肝病(ALD)的进展中定义了一个重要阶段,这是全世界发病率和死亡率的主要原因。目的:建立ADLD的小鼠模型。方法:将雄性C57BL / 6小鼠分为以下两组:(i)对照组,其被自由获得食物和水,(ii)饮酒治疗组,其施用15%(v / v)醇溶液代替水。使用自动化生物化学分析仪测量8-9个月的治疗,血清生化指标,组织病理学变化,肝脏甘油三酯含量,铁储存和铁蛋白轻链蛋白表达,血红素 - 嗜素(HE)染色,普鲁士蓝染色和Western印迹分析。结果:与对照组相比,醇治疗组均显示血清LDH,ALT和AST的水平增加,ALA1水平降低,TP水平没有显着变化。另外,在醇处理的小鼠中,观察到增加血清Tg,T-cho和LDL水平和血清Glu和HDL的水平降低。他染色表明,血液液体发生在酒精处理的小鼠的肝脏中。醇处理的小鼠还表现出增加的肝甘油三酯含量。此外,普鲁士蓝染色和Western印迹分析表明,慢性醇给药导致肝脏的铁过载。结论:慢性施用15%(v / v)酒精在饮用水中超过8-9个月导致小鼠的Add。我们的结果建立了一个AFLD模型,代表了一个有前途的工具,以便未来的ALD进展的研究。

著录项

  • 来源
  • 作者单位

    Harbin Med Univ Dept Biochem &

    Mol Biol 194 XueFu Rd Harbin 150000 Heilongjiang Peoples R China;

    Harbin Med Univ Dept Biochem &

    Mol Biol 194 XueFu Rd Harbin 150000 Heilongjiang Peoples R China;

    Harbin Med Univ Dept Biochem &

    Mol Biol 194 XueFu Rd Harbin 150000 Heilongjiang Peoples R China;

    Harbin Med Univ Dept Biochem &

    Mol Biol 194 XueFu Rd Harbin 150000 Heilongjiang Peoples R China;

    Harbin Med Univ Dept Biochem &

    Mol Biol 194 XueFu Rd Harbin 150000 Heilongjiang Peoples R China;

    Harbin Med Univ Dept Biochem &

    Mol Biol 194 XueFu Rd Harbin 150000 Heilongjiang Peoples R China;

    Harbin Med Univ Dept Biochem &

    Mol Biol 194 XueFu Rd Harbin 150000 Heilongjiang Peoples R China;

    Harbin Med Univ Dept Biochem &

    Mol Biol 194 XueFu Rd Harbin 150000 Heilongjiang Peoples R China;

    Harbin Med Univ Dept Biochem &

    Mol Biol 194 XueFu Rd Harbin 150000 Heilongjiang Peoples R China;

    Harbin Med Univ Dept Biochem &

    Mol Biol 194 XueFu Rd Harbin 150000 Heilongjiang Peoples R China;

    Harbin Med Univ Dept Biochem &

    Mol Biol 194 XueFu Rd Harbin 150000 Heilongjiang Peoples R China;

    Heilongjiang Prov Hosp Dept Gastroenterol 194 XueFu Rd Harbin 150000 Heilongjiang Peoples R;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学 ;
  • 关键词

    Alcoholic fatty liver disease (AFLD); alcoholic liver disease (ALD); serum biochemical indexes; triglyceride; iron;

    机译:酒精性脂肪肝疾病(AFLD);酒精性肝病(ALD);血清生化指标;甘油三酯;铁;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号